P-266 Outcomes in advanced hepatocellular carcinoma (HCC) patients (pts) treated with immune checkpoint inhibitors (ICI)

• DOI: 10.1016/j.annonc.2023.04.322
• Publication Date: 2023-07-01T15:20:28Z
• Authors: D. Cowzer; M. Capanu; F. Keane; D. Khalil; J. Shia; R. Do; J. Chou; H. Walch; I. El Dika; A. Yaqubie; D. Solit; M. Berger; E. O'Reilly; J. Harding; G. Abou-Alfa